Hospitals are aligning purchasing strategies accordingly. In Q1 and Q2 of 2024, biventricular pacemaker market leaders like Medtronic, Abbott, and Boston Scientific released AI-powered CRT devices ...

Despite the positive results, there are open questions about LBB pacing, including long-term lead performance. RCTs are ...

Omniasecure, which was authorized for placement in the heart’s right ventricle, is the world’s smallest defibrillation lead, ...

Medtronic (NYSE: MDT) announced that it received FDA approval for its OmniaSecure defibrillation lead for right ventricle ...

The device is designed to lower blood pressure while simultaneously modulating the autonomic nervous system by delivering ...

Medtronic (NYSE: MDT) announced that it entered into an agreement to distribute the Retia Medical Argos cardiac output ...

LBBP is defined as capturing the left bundle branch (LBB) trunk or its fascicles, whereas capturing only the left septal ...

Medtronic confirmed that its Hugo surgical robot system has been submitted to the FDA for review, alongside the successful completion of a large clinical trial evaluating its performance in multi ...

GALWAY, Ireland, April 24, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it has submitted 510(k) applications to the U.S. Food and Drug ...

Medtronic said its OmniaSecure device can be used to treat potentially life-threatening conditions including ventricular tachyarrhythmias, a heart rhythm disorder where the heart's lower chambers beat ...